DNLI Operating Cash Flow (Statement)
Denali Therapeutics Inc · Operating Cash Flow (Statement)
DNLI Operating Cash Flow (Statement)
Latest reported-$434.04Mperiod ending
DNLI Cash from Operations (-$15.05M → -$434.04M)
Annual operating cash flow (statement)
High-resolution chart · PNG
DNLI operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -412,600,000 | |
| -347,694,000 | |
| -357,991,000 | |
| -244,716,000 | |
| -211,389,000 | |
| 416,152,000 | |
| -151,576,000 | |
| 50,116,000 | |
| -76,635,000 | |
| -72,359,000 | |
| -15,052,000 |